Sökning: onr:"swepub:oai:lup.lub.lu.se:deeed8a5-91cf-495f-b1e4-35d7216d646f" >
Transradial versus ...
-
Desta, LiyewKarolinska Institutet,Division of Cardiology, Department of Medicine, Karolinska Institute Huddinge and Karolinska University Hospital, Stockholm, Sweden
(författare)
Transradial versus trans-femoral access site in high-speed rotational atherectomy in Sweden
- Artikel/kapitelEngelska2022
Förlag, utgivningsår, omfång ...
Nummerbeteckningar
-
LIBRIS-ID:oai:lup.lub.lu.se:deeed8a5-91cf-495f-b1e4-35d7216d646f
-
https://lup.lub.lu.se/record/deeed8a5-91cf-495f-b1e4-35d7216d646fURI
-
https://doi.org/10.1016/j.ijcard.2022.01.039DOI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:149593407URI
-
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-193354URI
-
https://gup.ub.gu.se/publication/313208URI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:art swepub-publicationtype
-
Ämneskategori:ref swepub-contenttype
Anmärkningar
-
Background: Radial artery is the preferred access site in contemporary percutaneous coronary intervention (PCI). However, limited data exist regarding utilization pattern, safety, and long-term efficacy of transradial artery access (TRA) PCI in heavily calcified lesions using high-speed rotational atherectomy (HSRA). Methods: All patients who underwent HSRA-PCI in Sweden between 2005 and 2016 were included. Outcomes were major adverse cardiac events (MACE, including death, myocardial infarction (MI) or target vessel revascularisation (TVR)), in-hospital bleeding and restenosis. Inverse probability of treatment weighting was used to adjust for the non-randomized access site selection. Results: We included 1479 patients of whom 649 had TRA and 782 transfemoral artery access (TFA) HSRA-PCI. The rate of TRA increased significantly by 18% per year but remained lower in HSRA-PCI (60%) than in the overall PCI population (85%) in 2016. TRA was associated with comparable angiographic success but significantly lower risk for major (adjusted OR 0.16; 95% CI 0.05–0.47) or any in-hospital bleeding (adjusted OR 0.32; 95% CI 0.13–0.78). At one year, the adjusted risk for MACE (HR 0.87; 95% CI 0.67–1.13) and its individual components did not differ between TRA and TFA patients. The risk for restenosis did not significantly differ between TRA and TFA HSRA-PCI treated lesions (adjusted HR 0.92; 95% CI 0.46–1.81). Conclusion: HSRA-PCI by TRA was associated with significantly lower risk for in-hospital bleeding and equivalent long-term efficacy when compared with TFA. Our data support the feasibility and superior safety profile of TRA in HSRA-PCI.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Jurga, JulianeKarolinska Institutet,Division of Cardiology, Department of Medicine, Karolinska Institute Solna and Karolinska University Hospital, Stockholm, Sweden
(författare)
-
Völz, Sebastian,1980Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine(Swepub:gu)xvolse
(författare)
-
Omerovic, Elmir,1968Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine(Swepub:gu)xomeel
(författare)
-
Ulvenstam, AndersDepartment of Internal Medicine and Cardiology, Östersund Hospital, Östersund, Sweden
(författare)
-
Zwackman, SammyLinköpings universitet,Linköping University,Avdelningen för diagnostik och specialistmedicin,Medicinska fakulteten,Region Östergötland, Kardiologiska kliniken US(Swepub:liu)samzw44
(författare)
-
Pagonis, ChristosLinköpings universitet,Linköping University,Avdelningen för diagnostik och specialistmedicin,Medicinska fakulteten,Region Östergötland, Kardiologiska kliniken US(Swepub:liu)chrpa43
(författare)
-
Calle, FredrikÖrebro University,Örebro University, Faculty of Health, Department of Cardiology, Örebro, Sweden
(författare)
-
Olivecrona, Göran K.Lund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Department of Cardiology, Lund University and HSkåne University Hospital, Lund, Sweden(Swepub:lu)kard-gol
(författare)
-
Persson, JonasDepartment of Clinical sciences, Danderyd Hospital, Karolinska Institute, Stockholm, Sweden
(författare)
-
Venetsanos, DimitriosDivision of Cardiology, Department of Medicine, Karolinska Institute Solna and Karolinska University Hospital, Stockholm, Sweden
(författare)
-
Karolinska InstitutetDivision of Cardiology, Department of Medicine, Karolinska Institute Huddinge and Karolinska University Hospital, Stockholm, Sweden
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:International Journal of Cardiology: Elsevier BV352, s. 45-510167-52731874-1754
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Desta, Liyew
-
Jurga, Juliane
-
Völz, Sebastian, ...
-
Omerovic, Elmir, ...
-
Ulvenstam, Ander ...
-
Zwackman, Sammy
-
visa fler...
-
Pagonis, Christo ...
-
Calle, Fredrik
-
Olivecrona, Göra ...
-
Persson, Jonas
-
Venetsanos, Dimi ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
- Artiklar i publikationen
-
International Jo ...
- Av lärosätet
-
Lunds universitet
-
Karolinska Institutet
-
Linköpings universitet
-
Göteborgs universitet